Literature DB >> 7681259

Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.

C D Gerharz1, R Moll, S Störkel, U Ramp, W Thoenes, H E Gabbert.   

Abstract

The clear, chromophilic, and chromophobe types of human renal cell carcinoma have been defined as distinct morphological entities and can be clearly separated by differences of ultrastructural appearance, cytoskeletal architecture, enzyme synthesis, and cytogenetic aberrations. In this report, the cytomorphological aspects of these tumor types are compared in vitro, showing that essential ultrastructural and cytoskeletal characteristics of each tumor type are expressed even after prolonged in vitro cultivation. The pattern of intermediate filament proteins of each tumor type was preserved in vitro, permitting the separation of exclusively cytokeratin-positive chromophobe tumor cells from clear and chromophilic tumor cells with a co-expression of vimentin and cytokeratins. In vitro, the chromophobe tumor cells continued to exhibit abundant cytoplasmatic microvesicles and sparsely distributed "studded" vesicles, which are known to be characteristic features of this tumor type in vivo. This observation confirmed the structural similarity of the chromophobe cell to the 'intercalated cell' of the cortical collecting duct and provided further evidence for the histogenetic derivation of this tumor subtype from the collecting duct system.

Entities:  

Mesh:

Year:  1993        PMID: 7681259      PMCID: PMC1886798     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  [Morphogenesis and micromorphology of epithelial tumors of the kidney of nitrosomorpholine intoxicated rats. I. Induction and histology (author's transl)].

Authors:  P Bannasch; U Schacht; E Storch
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

Review 2.  Human ultrastructure. IV. Collecting duct of healthy individuals.

Authors:  C E Myers; R E Bulger; C C Tisher; B F Trump
Journal:  Lab Invest       Date:  1966-12       Impact factor: 5.662

3.  Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins.

Authors:  S Bachmann; W Kriz; C Kuhn; W W Franke
Journal:  Histochemistry       Date:  1983

4.  Morphologic alterations in the rat medullary collecting duct following potassium depletion.

Authors:  D L Stetson; J B Wade; G Giebisch
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

5.  Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.

Authors:  H Holthöfer; A Miettinen; R Paasivuo; V P Lehto; E Linder; O Alfthan; I Virtanen
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

6.  Molecular and cellular characterization of human renal cell carcinoma cell lines.

Authors:  P Anglard; E Trahan; S Liu; F Latif; M J Merino; M I Lerman; B Zbar; W M Linehan
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

7.  Response of intercalated cells of rat outer medullary collecting duct to chronic metabolic acidosis.

Authors:  K M Madsen; C C Tisher
Journal:  Lab Invest       Date:  1984-09       Impact factor: 5.662

8.  [Morphogenesis and micromorphology of epithelial tumors induced in the rat kidney by nitrosomorpholine. IV. Tubular lesions and basophilic tumors (author's transl)].

Authors:  P Bannasch; R Krech; H Zerban
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Intracellular distribution of carbonic anhydrase in the rat kidney.

Authors:  G Lönnerholm; Y Ridderstråle
Journal:  Kidney Int       Date:  1980-02       Impact factor: 10.612

10.  Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys.

Authors:  H Holthöfer; A Miettinen; V P Lehto; E Lehtonen; I Virtanen
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

View more
  11 in total

1.  Myxoid renal cell carcinoma: histological, immunocytochemical and ultrastructural study.

Authors:  H A Birch; J M Glass; J Vale; M M Walker
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; B Hildebrandt; G Molsberger; P Koldovsky; H E Gabbert
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

Authors:  H J Terpe; S Störkel; U Zimmer; V Anquez; C Fischer; K Pantel; U Günthert
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

4.  A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens.

Authors:  Maria João Valente; Rui Henrique; Vera L Costa; Carmen Jerónimo; Félix Carvalho; Maria L Bastos; Paula Guedes de Pinho; Márcia Carvalho
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

5.  Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines.

Authors:  C D Gerharz; B Hildebrandt; R Moll; U Ramp; M Sarbia; S Störkel; P Koldovsky; H E Gabbert
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression.

Authors:  R Engers; S Mrzyk; E Springer; D Fabbro; G Weissgerber; C D Gernharz; H E Gabbert
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

7.  Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.

Authors:  U Ramp; M Dejosez; C Mahotka; B Czarnotta; T Kalinski; M Wenzel; I Lorenz; M Müller; P Krammer; H E Gabbert; C D Gerharz
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 8.  Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Authors:  Maximilian Seles; Georg C Hutterer; Tobias Kiesslich; Karl Pummer; Ioana Berindan-Neagoe; Samantha Perakis; Daniela Schwarzenbacher; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

9.  Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.

Authors:  U Ramp; E Caliskan; C Mahotka; A Krieg; S Heikaus; H E Gabbert; C D Gerharz
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

10.  AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.

Authors:  Minglei Wang; Xuefeng Li; Jin Zhang; Qiong Yang; Wenqi Chen; Weilin Jin; Yi-Ran Huang; Ru Yang; Wei-Qiang Gao
Journal:  Theranostics       Date:  2017-02-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.